Endocrine Testing Market is Estimated to Progress at a CAGR of 6.4% during the Forecast Period, notes TMR Study – GlobeNewswire

Posted: August 11, 2022 at 2:12 am

Wilmington, Delaware, United States, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The value of the global endocrine testing market stood at US$ 5.5 Bn in 2018. The global market study on endocrine testing expects the market to rise at a CAGR of 6.4% during the forecast period, from 2019 to 2027. The global market for endocrine testing is expected toexpand faster asmetabolic and endocrineproblems become more common. The marketis also anticipated to develop as diabetes prevalence rise across the globe.

Endocrine glands, which are a component of the endocrine system, produce hormones right into the bloodstream. Testing is done to check the levels of endocrine hormones in biological samples, including luteinizing hormone,follicle stimulating hormone, insulin,estradiol, and many others. These tests assist identify deviations in hormone secretion, such as hypersecretion or hyposecretion, which can lead to endocrine illnesses such asmenopause, infertility, thyroid dysfunction, and variousother conditions. Ongoing trends of the endocrine testing market

Endocrine testing has increased as a result of a number of illnesses, including various forms of diabetes and PCOS and it is also expected to present positive endocrine testing market outlook. For instance, a study reported in Current Diabetes Reports found a substantial increase in the incidence of PCOS and diabetes. Therefore, the rise in endocrine and metabolic diseases is a major driver that is predicted to fuel the expansion of the globalendocrine testing market in the years to come.

Get Exclusive PDF Sample Copy of Endocrine Testing Market Report https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645

Key Findings of Market Report

Ask for References https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=1645

Global Endocrine Testing Market: Key Players

Some of the key market players are

Make an Enquiry Before Buying https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1645

Global Endocrine Testing Market: Segmentation

Test Type

Diagnostic Technologies

End User

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Brachytherapy Devices Market: The brachytherapy applicators segment is estimated to expand at a CAGR of 8.4% and account for the dominant share of the brachytherapy devices market during the forecast period.

Hyperbaric Oxygen Therapy Devices Market: The global hyperbaric oxygen therapy devices market is expected to reach the value of US$ 7.3 Bn by the end of 2028.

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market: The global IBD (ulcerative colitis and Crohn's disease) treatment market was valued at ~US$ 15.5 Bn in 2018 and is projected to expand at a CAGR of ~6% from 2019 to 2027.

Hemophilia Treatment Drugs Market: The global hemophilia treatment drugs market was valued at US$ 9,500 Mn in 2017 and is anticipated to reach US$ 15,000 Mn by 2026, expanding at a CAGR of 5% from 2018 to 2026.

Critical Limb Ischemia Treatment Market: The global critical limb ischemia treatment market is driven by rise in prevalence of critical limb ischemia. Growth of the market is also attributed to increase in awareness about critical limb ischemia and rich product pipeline.

Menopausal Hot Flashes Treatment Market: Growing population of elderly women worldwide coupled with rise in menopausal hot flashes symptoms is a major factor responsible for the growth of global menopausal hot flashes treatment market.

Substance Abuse Treatment Market: The global substance abuse treatment market is anticipated to cross US$ 23.1 Bn by 2031. The global market is projected to grow at a CAGR of 8.5% from 2022 to 2031.

Glioblastoma Multiforme Treatment (GBM) Market: The global glioblastoma multiforme (GBM) treatment market is expected to reach the value of US$ 3.72 Bn by the end of 2028.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit BhiseyTransparency Market Research Inc.CORPORATE HEADQUARTER DOWNTOWN,1000 N. West Street,Suite 1200, Wilmington, Delaware 19801 USATel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Website:https://www.transparencymarketresearch.comBlog:https://tmrblog.comEmail:sales@transparencymarketresearch.com

See the rest here:
Endocrine Testing Market is Estimated to Progress at a CAGR of 6.4% during the Forecast Period, notes TMR Study - GlobeNewswire

Related Posts

Comments are closed.

Archives